1. Home
  2. RYTM vs ACHR Comparison

RYTM vs ACHR Comparison

Compare RYTM & ACHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • ACHR
  • Stock Information
  • Founded
  • RYTM 2008
  • ACHR 2018
  • Country
  • RYTM United States
  • ACHR United States
  • Employees
  • RYTM 283
  • ACHR N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • ACHR Aerospace
  • Sector
  • RYTM Health Care
  • ACHR Industrials
  • Exchange
  • RYTM Nasdaq
  • ACHR Nasdaq
  • Market Cap
  • RYTM 6.9B
  • ACHR 6.3B
  • IPO Year
  • RYTM 2017
  • ACHR N/A
  • Fundamental
  • Price
  • RYTM $102.12
  • ACHR $8.51
  • Analyst Decision
  • RYTM Strong Buy
  • ACHR Strong Buy
  • Analyst Count
  • RYTM 13
  • ACHR 7
  • Target Price
  • RYTM $101.92
  • ACHR $13.43
  • AVG Volume (30 Days)
  • RYTM 550.8K
  • ACHR 26.0M
  • Earning Date
  • RYTM 11-04-2025
  • ACHR 08-11-2025
  • Dividend Yield
  • RYTM N/A
  • ACHR N/A
  • EPS Growth
  • RYTM N/A
  • ACHR N/A
  • EPS
  • RYTM N/A
  • ACHR N/A
  • Revenue
  • RYTM $156,287,000.00
  • ACHR N/A
  • Revenue This Year
  • RYTM $44.69
  • ACHR N/A
  • Revenue Next Year
  • RYTM $63.53
  • ACHR $636.40
  • P/E Ratio
  • RYTM N/A
  • ACHR N/A
  • Revenue Growth
  • RYTM 53.55
  • ACHR N/A
  • 52 Week Low
  • RYTM $45.91
  • ACHR $2.82
  • 52 Week High
  • RYTM $106.52
  • ACHR $13.92
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 60.62
  • ACHR 34.49
  • Support Level
  • RYTM $101.45
  • ACHR $9.06
  • Resistance Level
  • RYTM $106.52
  • ACHR $9.81
  • Average True Range (ATR)
  • RYTM 3.12
  • ACHR 0.40
  • MACD
  • RYTM -0.43
  • ACHR -0.08
  • Stochastic Oscillator
  • RYTM 65.84
  • ACHR 16.46

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About ACHR Archer Aviation Inc.

Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.

Share on Social Networks: